Valeant Pharmaceuticals shares were down over 5% in premarket trading Monday after the FDA failed to approve the company's lotion intended to treat plaque psoriasis.
Neon Therapeutics filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. The company intends to price its 6.25 million shares in the range of $15…
Affimed N.V. (NASDAQ: AFMD) shares dropped sharply early on Friday after the firm released new results from its early stage trial with Keytruda. The firm presented new interim data from the Phase 1b dose…
Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a time of uncertainty in global markets.
Nightstar Therapeutics PLC (NASDAQ: NITE) shares saw a massive gain on Thursday after the firm announced a crucial decision from the U.S. Food and Drug Administration (FDA). Essentially, the agency has granted Regenerative Medicine…
Merck & Co., Inc. (NYSE: MRK) shares took a small step back on Thursday after the company announced a key approval from the U.S. Food and Drug Administration. The agency has now approved Keytruda…
Albiero Pharma, Inc. (NASDAQ: ALBO) recently received some positive news from the U.S. Food and Drug Administration (FDA) and it could have huge implications for the stock. One analyst actually sees the stock more…
scPharmaceuticals Inc. (NASDAQ: SCPH) saw its shares drop massively on Wednesday after the firm announced that it had received a letter from the U.S. Food and Drug Administration. Essentially, the agency sent a Complete…
Analysts at Jefferies recently reviewed several pharmaceutical services company stocks and put a Buy rating on four outstanding performers.
Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the U.S. Food and Drug Administration…
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves in the selected…
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
Shares of CRISPR Therapeutics tumbled after a report was released that gene-edited cells might cause cancer. The implications of this study could be catastrophic for the company seeing as CRISPR is known for its…
Envision Healthcare Corp. (NYSE: EVHC) saw its shares make a slight bump early on Monday morning after it was announced that the firm would be acquired by KKR & Co. L.P. (NYSE: KKR). This…
Here 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
